Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

(2013) Jelena Savović et al.   ANNALS OF INTERNAL MEDICINE

Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors

(2013) A. Hrobjartsson et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Stem Cell–based Therapy for Prevention of Delayed Fracture Union: A Randomized and Prospective Preliminary Study

(2013) Meir Liebergall et al.   MOLECULAR THERAPY

Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group

(2011) A.M. Stone et al.   EUROPEAN JOURNAL OF CANCER

Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis

(2011) O. Amit et al.   EUROPEAN JOURNAL OF CANCER

Recombinant Human Bone Morphogenetic Protein-2: A Randomized Trial in Open Tibial Fractures Treated with Reamed Nail Fixation

(2011) Hannu T Aro et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Do Unblinded Assessors Bias Muscle Strength Outcomes in Randomized Controlled Trials of Progressive Resistance Strength Training in Older Adults?

(2010) Chiung-ju Liu et al.   AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION

Topic of Histopathology Blinding in Nonclinical Safety Biomarker Qualification Studies

(2010) John E. Burkhardt et al.   TOXICOLOGIC PATHOLOGY

Development and Application of a Real-Time On-Line Blinded Independent Central Review of Interim Pet Scans to Determine Treatment Allocation in Lymphoma Trials

(2009) Michel Meignan et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiographs of hip fractures were digitally altered to mask surgeons to the type of implant without compromising the reliability of quality ratings or making the rating process more difficult

(2008) Paul J. Karanicolas et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?

(2008) Lori E. Dodd et al.   JOURNAL OF CLINICAL ONCOLOGY